Reach Us +1-217-403-9671
Design And Evaluation Of Polymeric Ocular Drug Delivery System | 8257
ISSN: 0975-0851

Journal of Bioequivalence & Bioavailability
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Design and evaluation of polymeric ocular drug delivery system

2nd World Congress on Bioavailability & Bioequivalence: Pharmaceutical R & D Summit-2011 and International Conference on Pharmaceutics & Novel Drug Delivery Systems

Vrushali Kashikar, Indrajeet Gonjari and K. Jayveera

ScientificTracks Abstracts: JBB

DOI: 10.4172/2153-2435.10000S4

T he objective of the present study was to prepare ocular inserts of Moxifl oxacin. Th e inserts were fabricated by solvent casting technique, with an aim by achieving once a day administration in the treatment of conjunctivitis. Inserts were evaluated for fi lm thickness, weight variation, drug content, percentage moisture absorption and loss. In-vitro drug release studies were done using bi-chambered donar receiver compartment model. Th e optimized formulations were subjected to in-vivo studies using rabbits as an animal model and stability studies to assess the eff ectiveness of the formulations. Finally in-vitro and in-vivo correlation was established. In-vitro drug release data was treated according to zero, fi rst, Korsemeyer Peppas and Higuchi kinetics to access the mechanism of drug release. Formulations were found to be uniform in physicochemical parameter with a fewer variations. Plasticizer was found to infl uence in mechanical properties as well as modify the drug release rate of the fi lms. Prepared ocular inserts exhibited desired release within 24 h and found to be strongly revealing the effi cacy of in vitro-in vivo correlation. From stability studies inserts were remained stable both physically and chemically. No burst eff ect but a prolonged drug release was observed from all formulations. Th us it achieves target such as increased residence time, prolonged drug release, reduction in frequency of administration and may improve the patient compliance
Relevant Topics